148 related articles for article (PubMed ID: 9697671)
1. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Larsson R; Mulec H; Weiss L; Alaupovic P
J Am Soc Nephrol; 1998 Aug; 9(8):1482-8. PubMed ID: 9697671
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.
Samuelsson O; Mulec H; Knight-Gibson C; Attman PO; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P
Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency.
Samuelsson O; Aurell M; Knight-Gibson C; Alaupovic P; Attman PO
Nephron; 1993; 63(3):279-85. PubMed ID: 8446264
[TBL] [Abstract][Full Text] [Related]
4. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
[TBL] [Abstract][Full Text] [Related]
5. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
Attman PO; Samuelsson O; Alaupovic P
Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
[TBL] [Abstract][Full Text] [Related]
6. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
Kimak E; Solski J
Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
[TBL] [Abstract][Full Text] [Related]
8. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
9. The effect of decreasing renal function on lipoprotein profiles.
Attman PO; Samuelsson O; Alaupovic P
Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
[TBL] [Abstract][Full Text] [Related]
10. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
12. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
[TBL] [Abstract][Full Text] [Related]
13. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein metabolism and renal failure.
Attman PO; Samuelsson O; Alaupovic P
Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure.
Samuelsson O; Attman PO; Knight-Gibson C; Larsson R; Mulec H; Wedel H; Weiss L; Alaupovic P
Nephrol Dial Transplant; 1996 Nov; 11(11):2237-43. PubMed ID: 8941584
[TBL] [Abstract][Full Text] [Related]
17. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
Samuelsson O; Lee DM; Attman PO; Knight-Gibson C; Mullen JK; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1999; 82(4):306-11. PubMed ID: 10450032
[TBL] [Abstract][Full Text] [Related]
18. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
Alaupovic P; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Samuelsson O
Kidney Int; 2006 May; 69(10):1865-71. PubMed ID: 16572113
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.
Attman PO; Alaupovic P; Samuelsson O
Kidney Int Suppl; 1999 Jul; 71():S14-7. PubMed ID: 10412728
[TBL] [Abstract][Full Text] [Related]
20. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
